This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harada, H. Articles by Kato, S. Search for Related Content PubMed PubMed Citation Articles by Harada, H. Articles by Kato, S.

Cloning of Rabbit TR4 and Its Bone Cell-Specific Activity to Suppress Estrogen Receptor-Mediated Transactivation¹

Sumitomo Pharmaceuticals Research Center (H.H., M.N., Y.Ko.), Kasugadenaka, Konohana-ku, Osaka, 554; Department of Agricultural Chemistry (Y.Ku., R.M., C.H., S.M.), Faculty of Agriculture, Tokyo University of Agriculture, Sakuragaoka, Setagaya-ku, Tokyo, 156; Institute of Molecular and Cellular Biochemistry (S.K.), University of Tokyo, Yayoi, Bunkyo-ku, Tokyo, 113; and CREST (S.K.), Japan Science and Technology Corporation, Honcho, Kawaguchi, Saitama 332, Japan

Address all correspondence and requests for reprints to: Shigeaki Kato, Ph.D., Institute of Molecular and Cellular Biochemistry, University of Tokyo, Yayoi, Bunkyo-ku, Tokyo, 113, Japan. E-mail: uskato{at}hongo.ecc.u-tokyo.ac.jp

To clone a new nuclear receptor, we screened a rabbit heart complementary DNA (cDNA) library with degenerate oligonucleotide probes corresponding to the DNA-binding domain of nuclear receptors, which is highly conserved among receptors. One of the cDNA clones, clone 23, encodes a novel protein of 596 amino acids, and predicted molecular mass is 66 kDa. Homology search analysis identified this protein as rabbit TR4 (TR4–0). We also cloned the cDNA encoding a rabbit TR4 isoform (TR4–1), which lacks the putative C-terminal ligand-binding domain (350 amino acids) caused by a 23-bp exon deletion, which probably occurred during messenger RNA (mRNA) splicing. Northern blot analysis showed that TR4s are expressed with two kinds of mRNAs (9.0 kb and 2.8 kb), both of which are relatively abundant in brain, testis, and bone. RT-PCR analysis, using pairs of primers specific for each TR4, showed that both types of receptor express in various tissues. Furthermore, both are present in primary osteoblasts and bone marrow cells, though the mRNA levels of TR4–0 were much higher than those of TR4–1. A functional study, using a transient transfection assay, showed that both receptors suppressed retinoid X receptor (RXR)-retinoid acid receptor, RXR-TR, and RXR-VDR-mediated transactivation significantly in COS-1 and osteosarcoma cells (UMR-106, ROS17/2.8) and that TR4–0 was much more effective than TR4–1. Unexpectedly, we found that the TR4s effectively suppressed estrogen receptor-mediated transactivation in bone cells, but neither in kidney (COS-1) nor breast cancer cells (MCF-7, one of the major target cells of the estrogen action). Thus, the present study shows a novel property of the TR4 orphan receptor, acting as a bone cell-specific repressor in the estrogen receptor-mediated signaling pathway.

This article has been cited by other articles:

				N.-C. Liu, W.-J. Lin, E. Kim, L. L. Collins, H.-Y. Lin, I-C. Yu, J. D. Sparks, L.-M. Chen, Y.-F. Lee, and C. Chang Loss of TR4 Orphan Nuclear Receptor Reduces Phosphoenolpyruvate Carboxykinase Mediated Gluconeogenesis Diabetes, December 1, 2007; 56(12): 2901 - 2909. [Abstract] [Full Text] [PDF]

				H. Escriva, N. D. Holland, H. Gronemeyer, V. Laudet, and L. Z. Holland The retinoic acid signaling pathway regulates anterior/posterior patterning in the nerve cord and pharynx of amphioxus, a chordate lacking neural crest Development, March 8, 2003; 129(12): 2905 - 2916. [Abstract] [Full Text] [PDF]

				N. Yagishita, Y. Yamamoto, T. Yoshizawa, K. Sekine, Y. Uematsu, H. Murayama, Y. Nagai, W. Krezel, P. Chambon, T. Matsumoto, et al. Aberrant Growth Plate Development in VDR/RXR{gamma} Double Null Mutant Mice Endocrinology, December 1, 2001; 142(12): 5332 - 5341. [Abstract] [Full Text] [PDF]

				N. P. Koritschoner, J. Madruga, S. Knespel, G. Blendinger, B. Anzinger, A. Otto, M. Zenke, and P. Bartunek The Nuclear Orphan Receptor TR4 Promotes Proliferation of Myeloid Progenitor Cells Cell Growth Differ., November 1, 2001; 12(11): 563 - 572. [Abstract] [Full Text] [PDF]

				V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text]

				A. Murayama, K.-i. Takeyama, S. Kitanaka, Y. Kodera, Y. Kawaguchi, T. Hosoya, and S. Kato Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1{alpha},25(OH)2D3 in Intact Animals Endocrinology, May 1, 1999; 140(5): 2224 - 2231. [Abstract] [Full Text]

				H. Harada, S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, A. Yamaguchi, T. Komori, and M. Nakatsuka Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation J. Biol. Chem., March 12, 1999; 274(11): 6972 - 6978. [Abstract] [Full Text] [PDF]